The goal of this proposal is to standardize several critical assays in the field of primate immunology and provide valuable resources to investigators interested in conducting immunologic studies in non-human primates. It has become increasingly clear that the results of mouse immunology studies do not readily apply to humans. Increasing interest is being focused on the non-human primate for preclinical studies of immune-based therapies for a number of human diseases and conditions. Using the NIH website and the Computer Retrieval of Information on Scientific Projects search engine, we found 51 NIH grants that listed nonhuman primates and immunology as keywords. There is broad interest among biomedical scientists and within the NIH to pursue studies which require the assessment of immunity in nonhuman primates. However, immunologic studies using non-human primates are hampered by a lack of standard reagents and protocols for assessing immune responses. This problem will be directly dealt with in this proposal. We intend to produce standardized reagents and protocols for assessing immunity in nonhuman primates, specifically the rhesus macaque. We intend to distribute the protocols and reagents we develop to interested scientists through publications in scientific journals and a Primate Immunology page that we have created and will post on the World Wide Web. We will also train visiting scientists, technicians and students on the use of these reagents, protocols and procedures. We do not expect that the protocols we develop here will perfectly fit the needs of all investigators pursuing specific studies in the numerous nonhuman primate models. However by producing rigorously tested experimental protocols for cellular immune assays, we will provide investigators that are moving into primate studies a ready source of model protocols which can be adapted to their specific system. The approach described here will place the nonhuman primate resource in a position to facilitate the translation of knowledge from animal studies into clinical approaches for the prevention and treatment of human diseases such as infectious diseases, cancer, autoimmunity and transplant rejection. This type of sustained support for assay development is required if immune studies in non-human primates are going to significantly advance in the near future.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Resource-Related Research Projects (R24)
Project #
5R24RR014555-03
Application #
6394756
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
Robinson, Jerry
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
3
Fiscal Year
2001
Total Cost
$663,901
Indirect Cost
Name
University of California Davis
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Busch, Marc; Abel, Kristina; Li, Jun et al. (2005) Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge. Vaccine 23:4036-47
Abel, Kristina; La Franco-Scheuch, Lisa; Rourke, Tracy et al. (2004) Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. J Virol 78:841-54
LaFranco-Scheuch, Lisa; Abel, Kristina; Makori, Norbert et al. (2004) High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum. J Virol 78:6399-408
Abel, Kristina; Rourke, Tracy; Lu, Ding et al. (2004) Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. J Infect Dis 190:1697-705
De Rosa, Stephen C; Lu, Fabien X; Yu, Joanne et al. (2004) Vaccination in humans generates broad T cell cytokine responses. J Immunol 173:5372-80
Busch, Marc; Lu, Ding; Fritts, Linda et al. (2003) Comparison of virology and immunology in SHIV 89.6 proviral DNA and virus-inoculated rhesus macaques. J Med Primatol 32:240-6
Abel, Kristina; Compton, Lara; Rourke, Tracy et al. (2003) Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon respon J Virol 77:3099-118
Pahar, Bapi; Li, Jun; Rourke, Tracy et al. (2003) Detection of antigen-specific T cell interferon gamma expression by ELISPOT and cytokine flow cytometry assays in rhesus macaques. J Immunol Methods 282:103-15
Izmailova, Elena; Bertley, Frederic M N; Huang, Qian et al. (2003) HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat Med 9:191-7
Miller, Christopher J; Lu, Fabien X (2003) Anti-HIV and -SIV immunity in the vagina. Int Rev Immunol 22:65-76

Showing the most recent 10 out of 16 publications